Mark Corrigan sold $217k of WVE
director at Wave Life Sciences Ltd.. 16,115 shares at an average of $13.48, traded Dec 8, 2025, filed Dec 10, 2025.
Score components
- +15RoleDirector
- +12Trade size$217k at market
- +10Share of holdings soldSold 36% of holdings
- +15Cluster8 insiders selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001193125-25-314735, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 8, 2025 | SOpen-market sale Ordinary Shares10b5-1 | -9,600 | $13.09 | $126k | 35,330 | Dec 10, 2025 |
| Dec 8, 2025 | SOpen-market sale Ordinary Shares10b5-1 | -6,515 | $14.07 | $92k | 28,815 | Dec 10, 2025 |
Related signals
Other insiders at Wave Life Sciences Ltd. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 36Weak | WVEsell Wave Life Sciences Ltd. | Paul Bolno President and CEO | $141k 10,480 shares | -4% | |
| 39Weak | WVEbuy Wave Life Sciences Ltd. | GSK plc owner | $28M 1,470,000 shares | +9% | |
| 40Moderate | Wave Life Sciences Ltd. | Chris Francis See Remarks | $6.4M 441,031 shares | -830% | |
| 40Moderate | Wave Life Sciences Ltd. | Christian O Henry director | $1.4M 93,445 shares | -488% | |
| 47Moderate | Wave Life Sciences Ltd. | Kyle Moran Chief Financial Officer | $4.1M 260,036 shares | -174% | |
| 35Weak | Wave Life Sciences Ltd. | Adrian Rawcliffe director | $630k 42,000 shares | -77% | |
| 40Moderate | Wave Life Sciences Ltd. | Aik Na Tan director | $1.8M 134,218 shares | -332% | |
| 23Weak | Wave Life Sciences Ltd. | Gregory L. Verdine director | $269k 20,000 shares | -7% | |
| 17Weak | Wave Life Sciences Ltd. | Heidi L Wagner director | $189k 14,000 shares | -27% | |
| 13Weak | WVEbuy Wave Life Sciences Ltd. | Ra Capital Management, L.p. director, owner | $6,688 1,000 shares | +0% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.